Sensei Biotherapeutics Inc (SNSE) — Strategic Asset Allocation Index
Sensei Biotherapeutics Inc (SNSE) has a Strategic Asset Allocation Index of 10.6% as of June 2023. Strategic assets (PP&E of $8.43 Million plus long-term investments of $-) total $8.43 Million, measured against net assets of $79.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Sensei Biotherapeutics Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Sensei Biotherapeutics Inc Strategic Asset Allocation Index (2020–2021)
This chart shows how Sensei Biotherapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 10.6%, representing strategic assets of $8.43 Million against net assets of $79.20 Million USD. For live market cap and overall valuation, see SNSE market cap.
Annual Strategic Asset Allocation Index for Sensei Biotherapeutics Inc (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Sensei Biotherapeutics Inc from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Sensei Biotherapeutics Inc (SNSE) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.2% | $4.64 Million | $4.64 Million | $- | $146.51 Million | ▼ -4.8 pp |
| 2020 | 8.0% | $1.27 Million | $1.27 Million | $- | $15.89 Million | — |